CRH Medical Corporation to Participate in the 2021 Annual ICR Conference
CRH Medical Corporation (CRHM) announced its participation in the 2021 Annual ICR Conference, scheduled from January 12-14.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
CRH Medical Corporation (CRHM) announced its participation in the 2021 Annual ICR Conference, scheduled from January 12-14. CEO Dr. Tushar Ramani and CFO Richard Bear will engage in a fireside chat on January 14 at 1:00 p.m. EST. A live audio webcast of the event will be available on CRH's Investors page.
CRH is dedicated to helping gastroenterologists in the U.S. with innovative services and products for gastrointestinal diseases, and has completed 31 anesthesia acquisitions across 68 ambulatory surgical centers in 13 states.
Details
News Market Reaction – CRHM
The recorded move for CRHM in the trading session of this news was -0.88%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
VANCOUVER, BC, Jan. 6, 2021 /PRNewswire/ - CRH Medical Corporation ("CRH", or the "Company") (TSX: CRH) (NYSE MKT: CRHM) today announced that Dr. Tushar Ramani, Chief Executive Officer, and Richard Bear, Chief Financial Officer, will attend the virtually held 2021 Annual ICR Conference from January 12th to the 14th. Management will participate in a fireside chat on Thursday, January 14th at 1:00 p.m. EST. A live audio webcast of the conference presentation will be accessible by visiting the "Events" section on the "Investors" page of CRH's website at https://investors.crhsystem.com.
About CRH Medical Corporation:
CRH Medical Corporation is a North American company focused on providing gastroenterologists throughout the United States with innovative services and products for the treatment of gastrointestinal diseases. In 2014, CRH became a full-service gastroenterology anesthesia company that provides anesthesia services for patients undergoing endoscopic procedures in ambulatory surgical centers. To date, CRH has completed 31 anesthesia acquisitions, and now serves 68 ambulatory surgical centers in 13 states. In addition, CRH owns the CRH O'Regan System, a single-use, disposable, hemorrhoid banding technology that is safe and highly effective in treating all grades of hemorrhoids. CRH distributes the O'Regan System, treatment protocols, operational and marketing expertise as a complete, turnkey package directly to gastroenterology practices, creating meaningful relationships with the gastroenterologists it serves. CRH's O'Regan System is currently used in all 48 lower US states.
View original content:http://www.prnewswire.com/news-releases/crh-medical-corporation-to-participate-in-the-2021-annual-icr-conference-301202344.html
SOURCE CRH Medical Corporation
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.